Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii
- PMID: 9743363
Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii
Abstract
Induction of reactive nitrogen intermediates by IFN-gamma is presumed an important mechanism of host resistance against acute and chronic infection with Toxoplasma gondii. Although nitric oxide (NO) has been shown to be important in the control of parasite replication in vivo, the role of this molecule in vaccine-based immunity against T. gondii is unknown. Mice with a targeted disruption of inducible NO synthase (iNOS) were immunized with an avirulent temperature-sensitive strain of this parasite (ts-4). Both the parental C57BL/6 and the iNOS(-/-) mice survived infection with the ts-4 mutant. Oral challenge of the vaccinated mice with a lethal dose of cysts containing bradyzoites resulted in reduced parasite burden and increased survival compared with nonvaccinated control mice. Host immunity in the iNOS(-/-) mice, similar to that observed in the parental strain, appears dependent upon both IFN-gamma and CD8+ T cells. These findings suggest that although vaccine-based long-term immunity against T. gondii is dependent upon the induction of IFN-gamma, it does not rely upon the anti-microbial effect of NO.
Similar articles
-
Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.J Immunol. 1999 Mar 15;162(6):3512-8. J Immunol. 1999. PMID: 10092808
-
Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo.J Immunol. 1998 Feb 1;160(3):1340-5. J Immunol. 1998. PMID: 9570552
-
IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.J Immunol. 1999 Oct 15;163(8):4503-9. J Immunol. 1999. PMID: 10510393
-
Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.Immunobiology. 1999 Dec;201(2):240-7. doi: 10.1016/S0171-2985(99)80064-3. Immunobiology. 1999. PMID: 10631573 Review.
-
Immunogenetics of Toxoplasma gondii informs vaccine design.Trends Parasitol. 2010 Nov;26(11):550-5. doi: 10.1016/j.pt.2010.06.004. Epub 2010 Jun 26. Trends Parasitol. 2010. PMID: 20580611 Review.
Cited by
-
Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection.Infect Immun. 1999 Apr;67(4):1887-93. doi: 10.1128/IAI.67.4.1887-1893.1999. Infect Immun. 1999. PMID: 10085032 Free PMC article.
-
Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.J Exp Med. 1999 Apr 5;189(7):1083-92. doi: 10.1084/jem.189.7.1083. J Exp Med. 1999. PMID: 10190899 Free PMC article.
-
Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.J Exp Med. 2002 Jun 3;195(11):1463-70. doi: 10.1084/jem.20011915. J Exp Med. 2002. PMID: 12045244 Free PMC article.
-
Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.Immunology. 2001 Nov;104(3):289-98. doi: 10.1046/j.1365-2567.2001.01319.x. Immunology. 2001. PMID: 11722643 Free PMC article.
-
Innate immunity to Toxoplasma gondii infection.Nat Rev Immunol. 2014 Feb;14(2):109-21. doi: 10.1038/nri3598. Nat Rev Immunol. 2014. PMID: 24457485 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases
Research Materials